Shows

video shows page features a feed of exclusive sereis, including Crisis Point and Rethinking Psychiatry with Dr. Steve Levine.

Despite recent advancements in medicine, there are still barriers and hurdles that prevent better care in all fields of medicine, including 

The effectiveness of treatments, whether or not a payer will in fact pay for the treatments, and the balance of patient needs and knowledge are all things that really hamper proper care for many with diseases like major depressive disorder (MDD) and generalized anxiety disorder (GAD).

These questions might only get more complicated in the next few years as more and more non-traditional treatments like esketamine become more commonly used to treat depression and other psychiatric disorders.

Rethinking Psychiatry with Dr. Steve Levine

, Dr. Levine is joined by Lisa Harding, MD, a clinical instructor with the Yale University School of Medicine, for a lively conversation with what is currently lacking in psychiatric care, particularly what do patients need and how do doctors properly gauge patient progress.

The discussion largely centered on how scaling patient needs ultimately can be improved in the future and why it is important for doctors to set realistic expectations for what a certain treatment will do and how fast.

While all doctors can be frustrated from time-to-time with the system, the 2 were hopeful that new treatments and better communication will ultimately have a positive impact on patients.

Videos

Dr. Levine talks with Dr. Lisa Harding about how clinicians can best improve patient care in psychiatry. 

Rethinking Psychiatry With Dr. Steve Levine: Episode 4

Every year new compounds and modalities for treatments are being developed, tested, and for the select few, approved to treat 

 disorders like major depression disorder and post-traumatic stress disorder.

The treatment pipeline may have never been as robust and promising as it currently is, with many in the industry excited about the prospect of adding psychedelics and other treatments showing promise for treatment-resistant depression to their armamentarium.

, Dr. Levine is joined by Sanjay John Mathew, MD, Vice Chair of Research at Baylor School of Medicine, to discuss some of the promising treatments in the pipeline, including ketamine.

There is a lot of money and attention spent in developing these types of compounds.

Dr. Mathew said there has never been something in the psychiatric drug space that has generated the interest of psychedelics as a viable treatment option, including psilocybin, DMT, LSD, and MDMA.

The two experts engaged in a lengthy and information-packed conversation about these treatments, what the concerns were, and whether or not it is hope or hype.

The discussion also centered on the current stable of treatments for patients with psychiatric disorders and why there is a need to develop new treatments.

Dr. Levine is joined by Dr. Sanjay Mathew to talk about some exciting treatments in the pipeline for psychiatric disorders.

Rethinking Psychiatry With Dr. Steve Levine: Episode 3

One does not need to matriculate through medical school to become an expert in 

Sometimes lived experiences can make someone an expert in mental health and really able to reflect on how to best promote mental health practices for themselves and others.

That is the case for Dave Bellevue, a vocalist for the band The Oxymorrons.

Dave has become a mental health advocate for many following the unfortunate suicide of a close friend. And since then Dave has sat and listened to experts on mental health and psychiatry and contemplated his own mental health.

And he has wanted to destigmatized asking for help among his friends and other people he may come across.

The days where you hide your true feelings and refuse to talk through your own mental health problems are over, at least for Dave.

, Bellevue shares his experiences and thoughts on the journey to help his own mental health and advocate for others with Dr. Levine.

The 2 shared an incredible candid and open conversation about how to talk about some of these issues and why things are changing in regard to mental health stigma, even among a notoriously tough group to reach—musicians.

Dave, who is also the Founder of Swag for Stigma, a mental health resource for Black, Indigenous, and people of color, explains his life, interests, and what he is doing to help others in episode 2 of 

Dave Bellevue of The Oxymorrons joins Steve to talk about his journey to mental health advocacy.

Rethinking Psychiatry With Dr. Steve Levine: Episode 2

What was already a growing mental health problem worldwide, was only made worse by a multi-year global pandemic.

And psychiatry is in the place where it must adapt to the times and continue to evolve with new treatments and practices to help address a new era of problems.

Dr. Levine, who is the SVP of Patient Access and Medical Affairs for COMPASS Pathways and a non-executive chairman for Heading Health, will lead 

In this monthly video series, Dr. Levine will speak with emerging thought leaders and patients about the new era of psychiatry.

These discussions will focus on new and non-traditional therapies, like psychedelics, the role of telehealth in the future, and how we can continue our research into the brain and the different roles brain function has in psychiatric disorders.

For the inaugural episode, Dr. Levine is joined by Gul Dolen, MD, PhD, associate professor of neuroscience at the Brain Science Institute of the Wendy Klag Center of Johns Hopkins University.

Dr. Dolen’s area of expertise centers on how the brain impacts social behaviors through basic neurobiological processes.

Dr. Dolen joined the show for an illuminating conversation on the brain and how critical periods in life shape some of the social behaviors that are seen later in life.

In the first episode of  Rethinking Psychiatry, Dr. Steve Levine is joined by Dr. Gul Dolen for a discussion on how the brain shapes social behavior.

Rethinking Psychiatry With Dr. Steve Levine

Psychiatrist Steve Levine, MD, talks monthly with thought leaders, researchers and advocates about the future of psychiatry, on topics from pioneering drug development to telemedicine and destigmatization.

Rethinking Psychiatry

Rethinking Psychiatry With Dr. Steve Levine: Episode 4

Rethinking Psychiatry With Dr. Steve Levine: Episode 3

Rethinking Psychiatry With Dr. Steve Levine: Episode 2

Rethinking Psychiatry With Dr. Steve Levine

Latest News